NICE draft guidance recommends pertuzumab for early treatment of breast cancer

NICE has published guidance recommending pertuzumab (Perjeta, Roche) for treating early HER2-positive breast cancer in people whose disease has spread to their lymph nodes.
Source: NHS Networks - Category: UK Health Source Type: news